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ABSTRACT
OBJECTIVE: The objective of the selective EBM review is to determine whether or not “Is
Curcuma effective for the management of osteoarthritis knee pain?”

STUDY DESIGN: Systematic review of three randomized controlled trials (RCT) published in
2009, 2014, and 2016.

DATA SOURCES: Three RCTs studies were found using PubMed. All articles were published
in reviewed journals and selected based on correlation to topic choice, date of publication, and
evaluation of POEMs.

OUTCOMES MEASURED: The Western Ontario and McMaster Universities Arthritis Index
(WOMAC) is a questionnaire that evaluates hip and knee osteoarthritis. The questions are
divided into 3 subscales: pain, stiffness, and physical function. This paper is focusing on the pain
scale when walking.

RESULTS: Kuptniratsaikul et al. (2014) found a decrease in knee pain on the pain scale with
Curcuma domestica with a statistically significant p-value of 0.018, showing it is as effective as
ibuprofen in pain reduction. Srivastava et al (2016) also shows a reduction in pain when using
Curcuma longa (CL) with diclofenac comparing to a placebo with Diclofenac group. With a
significant p-value of 0.0001, showing CL extract along with Diclofenac produces an overall
significant improvement in patients with knee OA. Kuptniratsaikul et al (2009) shows a
reduction in pain in both the Curcuma domestica group and ibuprofen group, but the differences
of the outcomes were not statistically significant with the p-value of 0.2. It cannot be definitively
concluded if Curcuma domestica is as effective as ibuprofen.

CONCLUSION: Two of the three studies shows statistical significance that Curcuma can reduce
pain in knee osteoarthritis. While one showed no statistical significance with knee OA pain
reduction, it is shown to be safe for the treatment of knee OA. Curcuma looks to be promising as
a long-term treatment, but further research needs to be done.

KEY WORDS: Curcuma, osteoarthritis
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INTRODUCTION
Osteoarthritis, abbreviated as OA, is the most common form of arthritis. OA is primarily
a disease of aging and with the increase of obesity the prevalence of OA is on the rise. It is
caused by degeneration of cartilage that protects the joints. The degeneration of cartilage starts in
a nonuniform manner and located focally, causing pain, swelling, and difficulty moving the
joints effected.1,2 Even though it can affect any joint, the most common joints affected are in the
hands, primarily the distal and proximal interphalangeal joints, as well as the knees, hips, and
spine.2 Symptomatically, OA of the knee is the most common joint affected, occurring in about
12% of people 60 years and older and 6% of adults 30 years and older in the United States. 2
The CDC estimates over 30 million US adults have OA. 1 It is especially common in the
geriatric population. There is no recent yearly healthcare visit for OA recorded, but in 2006
through 2007 there were 12.3 million office visits and 85,000 hospital visits associated with
OA.3 Since there are many options for the treatment of OA depending on the severity as well as
many treatment options that can be bought over the counter for mild OA, it is difficult to
calculate the total healthcare costs for OA, however, a 2013 study found the total hospitalization
cost of OA was $16.5 billion.4
The etiology of osteoarthritis is still not well understood. However, what is known is that
it is categorized as a gradual loss of articular cartilage and that there are many risk factors
involved. The most common risk factor is age. A study published in 1995 showed an increase
incidence of osteoarthritis with age.4 Typically, the incidence increased after the age of 50 then
leveled off or declined in both sexes after the age of 80.5 Trauma and overuse of the joint as well
as being overweight increases the risk of OA. Genetics has shown to play a role in OA as well.
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Studies have shown there is an increase of OA occurrence in monozygotic twins. 6 Other genetic
traits that have shown to increase OA are a defect in producing collagen, a defect in bones fitting
together, and a genetic defect called FAAH that increases pain sensitivity causing a higher risk of
developing OA.7 Other risk factors for OA are low bone density, low diet of vitamins C and D,
and ethnicity. OA is more prominent in Europeans than Asians and Africans. 2,7
Even though there is an understanding of the different risk factors for osteoarthritis, it is
unknown why OA can vary from person to person and why there is a faster progression in some.
Treatments are not considered curative, often resulting in joint replacement if it hinders the
patient’s activities in daily living.7 There is still much more that needs to be learned about this
common disease.
The methods to treat OA depend on the severity and pain of the joint affected. Usually
assisting devices are used along with exercise and weight loss, if applicable. Acetaminophen or
NSAIDs are used to control pain. If a patient has moderate to severe OA of the knee and oral
NSAIDs are ineffective, intra-articular injections of corticosteriods, hyaluronate, or platelet-rich
plasma can be administered to relieve pain temporally. If the knee or hip affected with OA
severely restricts the patient from walking and causes them pain at rest, then total joint
replacment is used to improve their mobility and pain. 2,8
Osteoarthritis can cause chronic use of NSAIDs which can lead to multiple health risks.
Chronic use of NSAIDs can lead to increased risk of peptic ulcer diease, acute renal failure,
decreased glomerular filtration rate, stroke, or a myocardial infarction. Since OA usually targets
the older population, the long-term use of NSAIDS can exacerbate heart failure and
hypertension.9 Curcuma, also known as turmeric, is a possible treatment method for OA pain.
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Curcuma contains anti-inflammatory properties that could possibility replace NSAID use.
Curcumin is shown to be well tolerated with few side effects. The most common side effects are
usually gastrointestinal, such as constipation, diarrhea, and nausea. 10 This paper evaluates three
randomized controlled trials comparing the efficacy of Curcuma extract as an oral medication for
improving osteoarthritis knee pain.
OBJECTIVE
The objective of the selected evidence-based medicine (EBM) review is to determine
whether or not, “Is Curcuma longa effective for the management of osteoarthritis knee pain?”
METHODS
The criteria used for the selection of the studies were based on the population,
interventions, comparisons, outcomes measures and types of studies. The population included
both female and male adult patients with knee OA. The studies compared Curcuma extract to
either ibuprofen or a placebo to determine a difference in the pain while walking. The pain was
measured by Western Ontario and McMaster Universities Osteoarthritis index (WOMAC). Three
randomized controlled trials were selected and evaluated for this paper. Two of which were
double blinded studies and one single blind RCT where the physicians were unaware of patients
group of treatment. Two of the studies compared Curcuma with ibuprofen and one study
compared Curcuma with a placebo.
In order to find the appropriate studies for this paper while searching through the data
sources, certain criteria was placed. Key-words included were “Curcuma” and “osteoarthritis”.
All articles were found in PubMed and are published in peer reviewed journals in English. The
articles were selected based on their applicability to the clinical question and included patient-
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oriented outcomes (POEMS). The inclusion criteria used were clinical trials, human studies, and
studies published in the past 10 years. Studies published greater than 10 years ago and studies on
animals were excluded. Statistics are reported using P-values.
Table 1. Demographics & Characteristics of Included Studies
Study
Type
# pts Age Inclusion criteria
Exclusion criteria
(yrs)
10
Kuptniratsaikul
Single
107
>50 >50 years with
Any patient with
(2009)
Blind
year primary knee OA,
peptic ulcer
RCT
s
morning stiffness
disease,
<30 minutes and
hepatobiliary tract
crepitus on motion.
disease, or known
With a pain score
allergy to
rating scale of ≥ 5 of ibuprofen or
10.
curcumin

W/D

Interventions

16

Controlled group
took ibuprofen
400mg b.i.d
daily, C.
domestica
extract patients
500 mg 4 times
daily for 6 weeks

Kuptniratsaikul11 Double
(2014)
blind
RCT

367

≥50
year
s

≥50 years, primary
knee OA with a
numerical rating
scale of knee pain of
≥5 out of 10

Patient with
36
abnormal liver
function or renal
function, history of
peptic ulcer,
allergy to curcuma
or ibuprofen,
unable to walk

Ibuprofen group
received 1,200
mg/day and C.
domestica
extract group
received
1,500mg/day for
4 weeks

Srivastava12
(2016)

160

4080
year
s

40-80 years old,
have knee OA with
stiffness <30 min,
crepitus, bony
tenderness, bony
enlargement and no
palpable warmth

Patients less than
40 or greater than
80 years old. Have
rheumatoid
arthritis, diabetes
mellites renal
insufficiency,
hepatic disease,
cardiovascular
disease, gout,
pregnant women,
with any systemic
disease

500mg placebo
with 50 mg/day
of Diclofenac,
500 mg
Curcuma longa
extract with 50
mg/day
Diclofenac for 4
months

Double
blind
RCT

27

Grinberg: Curcuma & OA knee pain 5
OUTCOMES MEASURED:
Two studies used Western Ontario and McMaster Universities Arthritis Index (WOMAC)
to measure the outcome for OA knee pain based on curcuma treatment. WOMAC is a
questionnaire that evaluates knee osteoarthritis. The questions are divided into 3 subscales: pain,
stiffness, and physical function. Each one of these subscales are numerically rated. The higher
number signifies more pain, more stiffness, or worst knee function. 11,12 One study used an
unspecified numerical scale to rate OA knee pain. 10 This paper focused on the pain scale while
walking.
Kuptniratsaikul et Al. 2009 randomly selected patients into two groups. One group was
treated by Curcuma and the other by ibuprofen. The patients walked 100m on a leveled surface
and rated their knee pain numerically. The numerical scale was not specified. The mean scores of
the outcomes were collected at weeks 0, 2, 4, and 6. 10 The physicians were unaware of which
group of patients they were treating.10 Kuptniratsaikul et al 2014 used WOMAC modified Thai
version comparing Curcuma to ibuprofen treatment. Patients walked for 6 minutes and then used
a 0-10 scale to quantify their knee pain. The outcomes were recorded at week 2 and 4. Double
blinding was achieved in this study.11 Srivastava et al compared Curcuma with a placebo group.
The outcomes used were WOMAC rating the knee pain from 0-4, as well as assessing the visual
analog scale (VAS) for knee pain. VAS is a questionnaire with a 10-cm horizontal line with
word description along with numerical numbers, ranging from 0-10. Zero indicating “no pain”
and 10 meaning “unbearable”.12 Patients were assessed on days 0, 60, and 120. Double blinding
was achieved in the study.12
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RESULTS
Two studies compared the effectiveness of Curcuma to ibuprofen for reducing OA knee
pain, and one study compared Curcuma with diclofenac to a placebo with diclofenac on OA knee
pain. All three studies selected patients for the study based off the knee OA guidelines issued by
the American College of Rheumatology. These guidelines consist of adults 50 years and older
with knee pain and stiffness lasting less than 30 minutes, along with crepitus and
osteophytes.10,11,12
Kuptniratsaikul et al 2009 was a single blind randomized control study that was
conducted in a tertiary hospital in Bangkok, Thailand. A total of 107 patients were selected. The
C. domestica extract group had 52 randomized patients and 55 were randomized to ibuprofen
group. At the end of the trial, 45 patients were left in the Curcuma group and 46 in the ibuprofen
group. Inconvenience for the follow up return and adverse reactions to either Curcuma or
ibuprofen caused patients to not complete the study, resulting in 86.5% compliance for Curcuma
and 83.6% for ibuprofen. One group received 500mg 4 times a day of Curcuma domestica
extract while the other received 400mg twice a day of ibuprofen for 6 weeks. They had patients
walk 100 meters on a level surface and then they rated their pain on a numerical scale. They
calculated the mean score of the rated pain as well as the change score for each group. The
confidence interval was obtained from the difference of change score for the past 6 weeks in both
groups.
The p-value of 0.2 was calculated showing that there is no statistical significance in OA knee
pain for Curcuma compared to ibuprofen even though the numerical pain score showed a
decrease in pain. The study states their wide range of the confidence interval showed an
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inadequate sample size. Another possible factor in a large confidence interval could be a large
age range and geographically limited study participants.
Table 2: change scale and Confidence interval of Pain on level walking between week 0 to
610
Change score of
C. Domestica

Change score of
ibuprofen

*Difference of
change score
P-Value
(95% CI)
Pain on level
2.7 ± 2.6
2.0±2.3
0.67
0.20
walking
(-0.35 to 1.68)
*Difference= change in score of C. domestica – Change in score of ibuprofen
Kuptniratsaikul et al 2014 conducted their double blind RCT in tertiary Thailand
hospitals.185 patients were randomly assigned to C. domestica and 182 to ibuprofen. At the end
of the trial there were 171 patients left for C. domestica and 160 for ibuprofen, making the
compliance for C. domestica 92.4% and 88.9% for ibuprofen. One patient from the C. domestica
withdrew from the adverse effects and 6 withdrew from ibuprofen. The rest were unable to be
contacted, inconvenienced, or left for other reasons which were not specified. The C. domestica
group was given 1,500 mg/day for 4 weeks and ibuprofen group were given a dosage of 1,200
mg/day for 4 weeks. The participants walked for 6 minutes then used the WOMAC pain scale,
rating the pain from 0 to 10. The p-value of 0.018 shows statistical significance since it is less
than 0.05.
Table 4. Mean Standard deviation (SD) and Mean Difference of WOMAC Pain at Week 4
Adjusted by Week 0 in Ibuprofen and Curcuma domestica Groups11
Mean score at
week 4 adjusted
by week 0 ±SD
WOMAC pain
scale

Ibuprofen
(n=160)

C. domestica
(n=171)

Mean difference
(95% CI)

3.17±1.98

3.25±2.11

-0.09
(-0.43 to 0.29)

P-value
0.018
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Srivastava et al conducted a 4-month double blinded RCT at the out-patient department
of orthopedics at King George’s Medical University, India. Inclusion and exclusion criteria can
be reviewed on table 1. Initially, 78 patients were randomly placed in Curcuma longa group and
82 in the placebo group. At the end of the 4 months, 66 patients from the Curcuma longa group
and 67 patients from the placebo group were analyzed, making 84.6% for Curcuma and 81.7%
for placebo completion. The reason for the low completion is that the patients failed to follow up.
Both groups received 500mg capsules twice daily. One group received Curcuma longa and the
other a placebo. Both groups also received 50mg of diclofenac daily. Patients were evaluated at
day 0, 60 and 120. OA knee pain was evaluated using VAS rating the pain 0 to 10 and WOMAC
pain scale of 0 to 4. The results were presented as mean with standard error. An unpaired t-test
was used to compare the variables among VAS and WOMAC scores. A paired t-test was used to
compare the mean change between days 0 to 120 from the VAS and WOMAC pain scores. A pvalue <0.05 is considered significant. The p-value of both scores showed a statistically
significant reduction in pain compared to the placebo group.
Table 6. Mean Change Comparison From Day 0 to 120 in VAS and WOMAC Pain Score 12

VAS score day 0
to day 120
WOMAC pain
score day 0 to
120

Curcuma Longa
(n=78)
Mean difference
3.91 ± 0.14

Curcuma Longa
(n=78)
p-value
0.0001

Placebo
(n=82)
Mean difference
2.54 ± 0.21

Placebo
(n=82)
p-value
0.0001

5.61 ± 0.34

0.0001

5.13 ± 0.33

0.0001
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DISCUSSION
Curcuma extracts can be found in many grocery stores or over the counter at a pharmacy.
However, many insurances are reluctant to cover it since herbal therapy falls under alternative
medicine. It is important to note that Medicare only covers chiropractors when it comes to
complementary and alternative medicine13. Herbal coverage is not covered under Medicare.
Curcumin is not currently widely used in pharmacology for its low systemic
bioavailability when used orally. Historically, tumeric has been used medically for centuries
throughout the world. It is widely used in India for wound healing properties and in China for
abdominal pain. Even though this herb has been around for centuries, there are not many clinical
trials on it.14 Clinical trials conducted on curcumin show its possible effectiveness are for allergic
rhinitis, depression, hyperlipidemia, and nonalcoholic fatty liver diease. It is a known antiinflammatory. Research shows it decreases inflammatory markers such as cytokines,
collagenase, elastase, and hyaluronidase.14,15 Curcumin is shown to be well tolerated with few
side effects. As noted in all 3 studies, the adverse effects are mild. Curcumin should be avoided
prior to surgery since it can slow blood clotting. It can also interact with anticoagulation and
antiplatelet medications since it increases bleeding.14 It can also interact with CYP2D6 and
CYP3A substrates. Patients with gall stones, bile duct, passage obstruction or turmeric
hypersensitivity should not take curcumin.15
There are some limitations that were found in the studies. Kuptniratsaikul et al 2009 had
an inadequate sample size, subtherapeutic dosage of 800mg/daily of ibuprofen given, and it was
not a double blinded study.10 Additionally, WOMAC and VAS scores are subjective. 12 All three
studies patients were sampled in either India or Thailand, which limits the generalizability. Pain
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and pain rating scores are also subjective, some patients had unilateral knee pain while others
were bilateral which can alter the pain score. The third study used rescue medication as an
edition to both the groups which could alter the pain score as well. The studies did not look into
what would happen if curcumin and ibuprofen were taken together.
CONCLUSION
Studies have shown Curcuma to be effective for knee OA pain with little adverse effects
and with fewer GI effects than ibuprofen.10, 15 Further research needs to be done since there were
some conflicting evidences with one of the studies and there are no studies conducted in the
United States population. Each study also used different amounts and types of Curcuma extracts.
The three studies show Curcuma is promising as a long-term treatment for knee osteoarthritis
pain, but further research is necessary.
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